SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 206 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120 | -53.8% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $260 | -26.1% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $352 | +35100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |